SMAD4 and hepatocellular carcinoma: Smad4 deletion in hepatocytes alleviates fibrosis-related hepatocarcinogenesis and increases CD8+ T cell infiltration by stimulating CXCL10 secretion, thereby inhibiting HCC progression.